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Editorial
Educating people with rare rheumatological
conditions
Patients deserve better
A disease is considered to be rare if it has a population
prevalence of< 5 in 10 000 [1]. Approximately 80% of rare
diseases are genetic and present in childhood. The re-
maining 20% are acquired and present in adulthood.
There are a number of rheumatic conditions that fall into
this category, including most of the vasculitides and many
of the connective tissue disorders. Rare diseases pose
numerous educational challenges to both health-care pro-
fessionals and patients; these can include ignorance of
the condition among health-care professionals and pa-
tients, or relatives and friends who may never have
heard of the condition. This leads to social and informa-
tional isolation because the patient has no one to turn to
for advice. Increasingly, patients are turning to internet
websites and chat rooms for advice, and some of these
may be of poor quality [2].
It has long been recognized that patients with more
common chronic rheumatic conditions, such as RA and
SLE, benefit from access to high-quality educational pro-
vision [3]. Development of an education resource for pa-
tients with SLE has been found to have a positive effect on
patients’ levels of knowledge [4]. It has been demon-
strated that people who clearly understand their illness
and actively participate in their treatment plans have im-
proved outcomes of care [5]; thus, educational pro-
grammes in common diseases have been shown to
influence patient outcome and self-efficacy. For patients
with a rare disease, there is much less educational provi-
sion. A survey carried out by Rare Disease UK on 600
patients and families found that there were significant
shortcomings in the education on how to live with a rare
condition [6]. Of these 600, 52% had not received suffi-
cient information about their condition and 37% had no
one to contact regarding questions about their illness [6].
We have previously shown in an exploratory qualitative
study using a combination of focus groups and one-to-
one interviews that patients with the chronic rare autoim-
mune disease ANCA-associated vasculitis (AAV) have
significant informational requirements that need to be tai-
lored to their specific needs and appropriate to their stage
of illness. This study also showed that patients reported
difficulty in assimilating information when acutely ill [7].
Those who join peer support groups, participate in re-
search and gain access to novel therapies tend to fare
better when coping with their disease [8].
A recent survey of patients with AAV conducted in both
the UK and USA explored their priorities for information
and preferred method of delivery. Using a validated infor-
mational needs questionnaire, we demonstrated that the
informational needs of vasculitis patients were high [9].
The most important areas for information provision were
disease diagnosis and management, with psychosocial
aspects of disease management given least importance.
There was no difference in informational needs according
to gender, age or disease duration. Comparison of the
needs of AAV patients with breast cancer patients revealed
that both required high levels of information, particularly
regarding the areas of disease and treatment. For both
vasculitis and cancer patients, information about psycho-
logical aspects was much less desired. The preferred
method of information delivery was that information be pro-
vided by a doctor and supported by written material.
What then is the best method of delivering such informa-
tion? In more common conditions, such as RA, there has
been a vogue for the development of group education pro-
grammes. The rarity of conditions such as AAV makes this
far more difficult except in the largest centres, where it is
easier to run regular educational groups at a time when
patients might need them. Patients will need information
at the time of diagnosis as well as at regular intervals sub-
sequently. Although groups are attractive as a means of
delivering education to several people at the same time, it
is not entirely clear from the experience in more common
diseases, such as RA, that they are the most effective
means of patient education [10]. Patients want information
delivered by an experienced health professional, but for
those with rare diseases, they often find that the right
health professionals are scattered and may not be readily
available. The development of networks within the National
Health Service to care for adults with complex and rare
rheumatic conditions might facilitate the development of
educational resources around the central hubs.
Patient support groups are important because many pro-
vide detailed information in an accessible form, which can
be downloaded for other family members to read. They
also offer telephone support, which may be crucial for pa-
tients with rare conditions because they find it difficult to
locate experienced people to talk to. Social media web-
sites, such as health unlocked (https://healthunlocked.
com/), provide a source of immediately available informa-
tion derived from other patients. These sites also provide
the opportunity to network with other patients, ask ques-
tions that may not have been discussed with a health pro-
fessional and cross-check information so that the
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consultation can be more effective for the patient. It is vital
that the health professional signpost the patient to accurate
sources of internet information and not leave the patient to
wander aimlessly, finding unreliable information.
Patients with rare diseases deserve education of the
same quality as that provided to patients with more
common conditions. Where possible, this should be pro-
vided face to face by an experienced health professional
with information appropriate to the condition and stage of
disease. Patient support groups and social media have an
increasingly important role in this provision.
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